Status:
COMPLETED
Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hyperglycemia
Malignant Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial studies computer-guided glucose management systems in treating patients with hyperglycemia who have undergone blood and bone marrow transplant. A computer-guided glucose management...
Detailed Description
PRIMARY OBJECTIVES: I. To examine the ability of computer-guided glucose management system (CGGMS) algorithms to control glucose within or close to current University of Washington Medical Center (UW...
Eligibility Criteria
Inclusion
- Post-transplant adult patients (age \>= 18 years) on the BMT Service at UWMC
- Requiring insulin secondary to:
- Known history of (h/o) type 2 diabetes mellitus
- Two blood sugar values \> 180 (point of care and/or am lab glycemia)
- One blood sugar value \> 250 (point of care or AM lab glycemia)
Exclusion
- Critically ill patients (intensive care unit \[ICU\] admissions)
- Terminally ill patients
- Eastern Cooperative Oncology Group (ECOG) performance status \> 3
- Previous type 1 diabetes mellitus
- Cognitively impaired patients, unable to consent
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01236885
Start Date
December 1 2012
Last Update
April 23 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114
2
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109